Medtronic PLC (MDT)
84.74
+0.63
(+0.75%)
USD |
NYSE |
Nov 21, 16:00
84.74
0.00 (0.00%)
After-Hours: 18:37
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 108.68B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 15.69% |
| Valuation | |
| PE Ratio | 25.91 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.364 |
| Price to Book Value | 2.241 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.70 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.5841 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 45.10% |
Profile
| One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales. |
| URL | https://www.medtronic.com |
| Investor Relations URL | https://investorrelations.medtronic.com |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Feb. 18, 2025 |
| Last Earnings Release | Nov. 19, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2024 |
Ratings
Profile
| One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales. |
| URL | https://www.medtronic.com |
| Investor Relations URL | https://investorrelations.medtronic.com |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | Large Cap/Value |
| Next Earnings Release | Feb. 18, 2025 |
| Last Earnings Release | Nov. 19, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Sep. 27, 2024 |